CONMED CORPORATION Excess Tax Benefit from Share-based Compensation, Financing Activities
CONMED CORPORATION (CNMD) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2018-02-26
- CONMED CORPORATION excess tax benefit from share-based compensation, financing activities for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- CONMED CORPORATION excess tax benefit from share-based compensation, financing activities for fiscal 2016 was $483.00K, a 88.16% decline from fiscal 2015.
- CONMED CORPORATION excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $4.08M, a 342.62% increase from fiscal 2014.
- CONMED CORPORATION excess tax benefit from share-based compensation, financing activities for fiscal 2014 was $922.00K, a 39.26% decline from fiscal 2013.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-26 |
| 2016-12-31 | $483.00K 10-K · filed 2018-02-26 |
| 2015-12-31 | $4.08M 10-K · filed 2018-02-26 |
| 2014-12-31 | $922.00K 10-K · filed 2017-02-27 |
| 2013-12-31 | $1.52M 10-K · filed 2016-02-23 |
| 2012-12-31 | $1.21M 10-K · filed 2015-02-23 |
| 2011-12-31 | $1.36M 10-K · filed 2014-02-24 |
| 2010-12-31 | $485.00K 10-K · filed 2013-02-25 |
| 2009-12-31 | $886.00K 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |